Saarland University

Running trials

• Recruiting

  A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

  NCT06793215· Phase 3· Source

• Recruiting

  Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension

  NCT07115953· Source

• Recruiting

  Digital Solutions for bEtter cAre

  NCT07416513· Source

• Recruiting

  Sex diffErences in prehoSpitAl Stroke MEdicine

  NCT06865950· Source

• Recruiting

  SPYRAL GEMINI Pilot Study

  NCT06907147· Source

• Recruiting

  Prevail Global Study

  NCT06535854· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic kidney disease2 recruiting
• High blood pressure2 recruiting
• Childhood cancers1 recruiting
• Coronary artery disease1 recruiting
• Lung cancer1 recruiting
• Stroke1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  New Generation IGRA in Immunocompromised Individuals

  NCT02639936· Source

• Completed

  Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma

  NCT01909453· Phase 3· Source

Trial sites

• Saarland University3 trials
• Universität Des Saarlandes5 trials

Conditions

Diseases this institution publishes on or runs trials for.

• Spinal muscular atrophy7 works · 0 trials
• High blood pressure6 works · 2 trials
• Primary biliary cholangitis4 works · 0 trials